Dr Samantha Wade

Dr Samantha Wade worked on a team that developed a drug delivery device aimed at improving outcomes for pancreatic cancer patients.

Supervised and guided by renowned cancer biologists, oncologists and material scientists, Dr Wade spent six years engineering the device. Although still in the pre-clinical stage of development, it could change how medicine is delivered.

Pancreatic cancer has a five-year survival rate of just 10 per cent. The device has the potential to make more cases curable and help patients avoid major surgery.

Dr Wade regularly attends cancer fundraising events and gives public presentations to fundraising bodies and community groups.